REVELATION BIOSCIENCES, INC.
Develops therapies that reprogram the innate immune system to reduce inflammation-related damage.
REVB | NDAQ
Overview
Corporate Details
- ISIN(s):
- US7164211028 (+4 more)
- LEI:
- Country:
- United States of America
- Address:
- 4660 LAJOLLA VILLAGE DRIVE, 92122 SAN DIEGO
- Website:
- https://www.revbiosciences.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Revelation Biosciences, Inc. is a clinical-stage life sciences company focused on developing therapies to prevent and treat disease by rebalancing inflammation. The company's therapeutic approach is centered on harnessing the innate immune system, a concept known as trained immunity. Its lead product candidate, Gemini, is a proprietary intravenous formulation of phosphorylated hexaacyl disaccharide (PHAD®). Gemini is designed to reprogram the immune system by stimulating the Toll-like receptor 4 (TLR-4), which primes the body to respond to stressors like infection and trauma in a more attenuated manner, thereby reducing inflammation-associated damage.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all REVELATION BIOSCIENCES, INC. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for REVELATION BIOSCIENCES, INC.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for REVELATION BIOSCIENCES, INC. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
